Research suggests that certain compounds found in Chrysanthemum indicum, particularly fargesin, may have theoretical relevance to migraine mechanisms, based on computational modeling work. The sole available study identified is an in silico investigation from 2024 that used molecular docking and pharmacokinetic simulations to assess fargesin's potential interactions with migraine-related biological targets, including CGRP and iNOS, finding favorable binding characteristics and predicted bioavailability. The direction of this preliminary evidence is supportive, but the research base is extremely limited and consists entirely of computer simulations with no animal or human trials conducted. Readers should be aware that computational findings of this kind represent an early and speculative stage of scientific inquiry, and no conclusions about clinical effectiveness can be drawn from this evidence alone.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Exploring the potential of Fargesin from Chrysanthemum indicum for chronic mi... | Other | 2024 | Supports | 72 |